CF PHARMTECH (02652) spent HK$421,300 to repurchase 12,000 shares on January 27th.
Changfeng Medicine (02652) announced that on January 27, 2026, it spent HKD 42.13 thousand to repurchase 12,000 shares.
CF PHARMTECH (02652) announced that it will spend HK$421,300 to repurchase 12,000 shares on January 27, 2026.
Related Articles
On January 27, Xuanwu Cloud (02392) spent approximately HK$92,100 to repurchase 64,000 shares.
CHI MED (00570) issues profit warning, expecting a net loss of approximately 350 to 500 million yuan in 2025.
China National Salt Industry Corporation's IPO on the Shanghai Stock Exchange main board has been requested for further information. It is the only state-owned enterprise in China that operates a comprehensive salt business platform.
On January 27, Xuanwu Cloud (02392) spent approximately HK$92,100 to repurchase 64,000 shares.
CHI MED (00570) issues profit warning, expecting a net loss of approximately 350 to 500 million yuan in 2025.
China National Salt Industry Corporation's IPO on the Shanghai Stock Exchange main board has been requested for further information. It is the only state-owned enterprise in China that operates a comprehensive salt business platform.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
